Skip to Content
  • Previous Rank431
  • Revenues ($M)$7,684
  • Revenue Percent Change28.1%
  • Profits ($M)$305.9
  • Profits Percent Change108.1%
  • Assets ($M)$26,684
  • Employees18,500
  • Market Value — as of March 31, 2017 ($M)$24,571

The medical device company sprung from the $14 billion mega merger between two orthopedic powerhouses, Zimmer and Biomet, in 2015. Since then, the company has seen its CEO resign abruptly and as of July 2017, it seemed to struggle meeting financial projections.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

Daniel P. Florin
CEO Title
Interim Chief Executive Officer & Director
Health Care
Medical Products and Equipment
HQ Location
Warsaw, IN
Years on Fortune 500 List2

Zimmer Biomet Holdings Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$7,68428.1%
Profits ($M)$305.9108.1%
Assets ($M)$26,684-
Total Stockholder Equity ($M)$9,669-
Market Value — as of March 31, 2017 ($M)$24,571-

Profit Ratios

Profit as % of Revenues4%
Profits as % of Assets1.1%
Profits as % of Stockholder Equity3.2%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)1.51
EPS % Change (from 2015)96.1%
EPS % Change (5 year annual rate)-17.8%
EPS % Change (10 year annual rate)-7.8%

Total Return

Total Return to Investors (2016)1.4%
Total Return to Investors (5 year, annualized)15.1%
Total Return to Investors (10 year, annualized)3.2%